Adcist 50mg Injection

Adcist 50mg Injection

Prescription requiredRx Required

Salt Composition: Cisplatin Injection IP

Expiry Date: 01/2028

Special offer

Price on Request

Price on Request

Inclusive of all taxes

1 vial(s)

About The Product

Advanced Cancer of the bladder, Advanced Cancer of the Testicles

Adcist 50 Injection contains cisplatin (50mg), which is a chemotherapy or antineoplastic medicine. It belongs to the medicative class of alkylating agents, which treat cancer by inhibiting or killing the growth of malignant cells. It acts by inhibiting the proliferation of cancer cells in the body.

Uses

Testicular tumor
Ovarian tumor
Bladder tumor
Lung cancer
Head and neck epithelial tumor
Cervical cancer

Side Effects

  • Undesired symptoms or responses vary from person to person as the human body reacts differently to the Adcist 50 Injection, but they typically resolve naturally within a few days as the body adjusts to the medicine, requiring no medical attention.
  • In case these symptoms don't go away and you face severe side effects, then immediately consult your doctor or medical team.
  • Some of the common side effects of the Adcist 50 Injection are: Fatigue Headache Fever loss of appetite Nausea Low blood count hair loss Diarrhea or constipation

How To Use

  • Adacist 50 Injection is given slowly in the veins; it is generally advised to receive lots of water before and after the injection to protect the kidneys.
  • Do not use the same injection or syringe for another injection, as there is a chance of interaction.
  • Always check the vial of injection before using it for discoloration or any kind of particulate matter, and shake well for uniform mixing of the product.
  • Adcist 50 Injection is administered once every 3-4 weeks or for 5 consecutive days.
  • Always consult your doctor before taking the vaccine, especially if you have a family history of blood disorders, heart problems, lung problems, pain in the limbs, or kidney problems.

How It Works

Cisplatin, which is present in the Adcist 50 injection, cross-links with the DNA, and it damages the DNA (genetic material) present in the cancer cells.

After the drug enters cells, it forms a strong bond with the DNA, preventing the cancer cells from synthesizing or copying their genetic material, hence stopping the growth and division of cancer cells.

Safety Advice

Alcohol
Excessive alcohol consumption can decrease the immunity of the individual and weaken the liver function. However, moderate levels of alcohol do not interfere with the working of the Adcist 50 Injection, as per the research.
Pregnancy
The Adcist 50 Injection should be injected after consulting the doctor; during pregnancy, it is not suggested to take it routinely. The Adcist 50 Injection can be injected in case of severe, life-threatening conditions. However, it may harm the unborn.
Breast Feeding
The Adcist 50 Injection is considered unsafe to be taken while breastfeeding, as there is a chance that it may pass to the developing baby through the breast milk of the mother. It is generally considered unsafe, and there is no clear evidence found in the clinical data that how it harms the baby.
Driving
Driving after taking the Adcist 50 Injection does not affect or interfere with driving ability or disturb while operating machinery. However, if you get a fever or dizziness after the injection, avoid driving until you feel better.
Kidney
The Adcist 50 Injection is considered unsafe for people with kidney problems. It contains cisplatin, which can damage the kidneys.
Liver
The Adcist 50 Injection is generally considered beneficial and safe for people with mild to moderate liver disease.

FAQs

During pregnancy, it is not safe to take Adcist 50 Injection, as it can cause harm to the unborn baby. Also, during breastfeeding, this medicine must not be used.

Please make sure to consult your healthcare provider regarding the same.

Reference

Desoize, B., & Madoulet, C. (2022).

Particular aspects of platinum compounds are used at present in cancer treatment. Critical reviews in oncology/hematology, 42(3), 317-325.

Frezza, M., Hindo, S., Chen, D., Davenport, A., Schmitt, S., Tomco, D., & Ping Dou, Q. (2021).

Novel metals and metal complexes as platforms for cancer therapy. Current pharmaceutical design, 16(16), 1813-1825.

Mrdenovic, S., Wang, Y., Yin, L., Chu, G. C.

Y., Ou, Y., Lewis, M. S., & Zhang, Y.

(2023). A cisplatin conjugate with tumor cell specificity exhibits antitumor effects in renal cancer models.

BMC cancer, 23(1), 499. Nagai, H., & Kim, Y.

H. (2025).

Cancer prevention from the perspective of global cancer burden patterns. Journal of Thoracic Disease, 9(3), 448.

Ranasinghe, R., Mathai, M. L., & Zulli, A.

(2022). Cisplatin for cancer therapy and overcoming chemoresistance.

Heliyon, 8(9).

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026